EML4 and non-small cell lung carcinoma: Additionally, in 2018, Shuangyan et al. reported that f-circEA2a, originating from a distinct EML4-ALK translocation, induced migration and invasion in non-small-cell lung cancer cells [110], suggesting a biological contribution of ALK-breakpoint derived fusion circRNAs to the tumor phenotype.